BROWSE·page 503 of 605

Browse EX-10 agreements

7,253 matching material contract exhibits.


EX-10.2

Alphatec Holdings, Inc.

ALPHATEC HOLDINGS, INC.

EMPLOYEE STOCK PURCHASE PLAN

ARTICLE I Purpose

The Plan is intended to provide employees of the Company and its Participating Subsidiaries with an opportunity to acquire a proprietary interest in the Company through the purchase of shares of Common Stock. The Company intends that the Plan qualify as an “employee stock purchase plan” under Section 423 of the Code and the Plan shall be interpreted in a manner that is consistent with that intent.

ARTICLE II Administration

…

EX-10.2·8-K·CIK 1350653·ACC 0001193125-26-267552·Filed Jun 11, 2026, 16:13 ET

EX-10.1

Parabilis Medicines, Inc.

STOCK PURCHASE AGREEMENT

This STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of June 9, 2026 (the “Effective Date”), by and between Regeneron Pharmaceuticals, Inc. (the “Investor”), and Parabilis Medicines, Inc., a Delaware corporation (the “Company”).

WHEREAS, the Company is proposing to issue and sell to the Investor (the “Offering”) $75,000,000 of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), contemporaneously with the Company’s initial public offering of Common Stock (“IPO”), pursuant to the terms and subject to the conditions set forth in this Agreement;

WHEREAS, the closing of the Offering shall take place concurrently with the closing of the IPO (the “IPO Closing Time”) and at a price per share equal to ninety percent (90%) of the initial public offering price per share that the Common Stock is sold to the public in the IPO as set forth on the cover of the final prospectus filed with the U.S. Securities and Exchange Commission (the “SEC”) (the “IPO-Based Purchase Price”);

…

EX-10.1·8-K·CIK 1657677·ACC 0001193125-26-267550·Filed Jun 11, 2026, 16:12 ET

Execution Version

 

Published CUSIP Number:

00783SAA9

 

Revolving Loan Facility CUSIP Number:

00783SAB7

  

CREDIT AGREEMENT

 

Dated as of June 10, 2026

 

among

 

AECOM

and

CERTAIN SUBSIDIARIES OF AECOM,

 

as Borrowers,

 

BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender,

 

And

The Other Lenders Party Hereto

 

JPMORGAN CHASE BANK, N.A., BNP PARIBAS SECURITIES CORP., and TRUIST BANK,

as Co-Syndication Agents

 

CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, PNC CAPITAL MARKETS LLC,

and HSBC SECURITIES (USA) INC.,

as Joint Lead Arrangers and Co-Documentation Agents

 

BANK OF AMERICA, N.A., JPMORGAN CHASE BANK, N.A., BNP PARIBAS SECURITIES CORP., and

TRUIST SECURITIES, INC.,

as Joint Lead Arrangers and Joint Bookrunners

 

 

 

 

TABLE OF CONTENTS

 

 

Page

ARTICLE I DEFINITIONS AND ACCOUNTING TERMS

1

1.01

Defined Terms

43

1.02

Other Interpretive Provisions

43

1.03

Accounting Terms

43

1.04

Rounding

45

1.05

Currency Equivalents Generally

45

1.06

[Reserved]

45

1.07

[Reserved]

45

1.08

…

EX-10.1·8-K·CIK 868857·ACC 0001104659-26-072942·Filed Jun 11, 2026, 16:11 ET

EXHIBIT 10.2

VSEE HEALTH, INC.

THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF, MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF, PURSUANT TO THE TERMS OF THIS NOTE.

VSEE HEALTH, INC.

 

Secured Promissory Note

 

Original Issuance Date: June 08, 2026

…

EX-10.2·8-K·CIK 1864531·ACC 0001185185-26-002468·Filed Jun 11, 2026, 16:11 ET

EXHIBIT 10.1

VSEE HEALTH, INC.

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 8, 2026, by and between VSEE HEALTH INC., a Delaware corporation, with its address at 980 N Federal Highway Boca Raton, FL 33432 (the “Company”), and ADI Funding LLC, a Florida limited liability company, with its address at 7050 Aloma Ave, Winter Park, Florida 32792 (the “Buyer”).

 

WHEREAS:

 

A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”); and

 

B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement, a promissory note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $271,739.13 (including $21,739.13 of Original Issue Discount) (the “Note”).

…

EX-10.1·8-K·CIK 1864531·ACC 0001185185-26-002468·Filed Jun 11, 2026, 16:11 ET

EXHIBIT 10.1

VSEE HEALTH, INC.

STANDBY EQUITY PURCHASE AGREEMENT

THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of June 2, 2026 is made by and between YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”), and VSEE HEALTH, INC., a company incorporated under the laws of the State of Delaware (the “Company”). The Investor and the Company may be referred to herein individually as a “Party” and collectively as the “Parties.”

WHEREAS, the Parties desire that, upon the terms and subject to the conditions contained herein, the Company shall have the right to issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $10 million of the Company’s common stock, par value 0.0001 per share (the “Common Shares”);

WHEREAS, the Common Shares are listed for trading on the Nasdaq Stock Market under the symbol “VSEE;”

…

EX-10.1·8-K·CIK 1864531·ACC 0001185185-26-002467·Filed Jun 11, 2026, 16:10 ET

EX-10.1

REED'S, INC.

Reed’s, Inc.

2026 Equity Incentive Plan

Adopted by the Board of Directors: March 31, 2026

 Approved by the Stockholders: June 10, 2026

 

1.

General.

(a) Successor to Prior Plans. The Plan is the successor to the Prior Plans. As of the Effective Date, (i) no additional awards may be granted under the Prior Plans; and (ii) all outstanding awards granted under the Prior Plans will remain subject to the terms of the Prior Plans. All Awards granted under this Plan will be subject to the terms of this Plan.

 

(b) Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

…

EX-10.1·8-K·CIK 1140215·ACC 0001493152-26-028280·Filed Jun 11, 2026, 16:10 ET

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

PROMISSORY NOTE

 

 

Dated as of June 11, 2026

 

 

Principal Amount: Up to $1,500,000

New York, NY

…

EX-10.1·8-K·CIK 2016221·ACC 0001213900-26-067825·Filed Jun 11, 2026, 16:10 ET

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 5, 2026, is by and between Leonite Fund I, LP, a Delaware limited partnership (the “Investor”), and Cardiff Lexington Corporation, a Nevada corporation (the “Company”).

 

RECITALS

 

A.The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), pursuant to which the Company may issue to the Investor, from time to time, up to $25,000,000 of the Company’s common stock, par value $0.001 per share (the “Common Stock”), which can be increased, at the Company’s option, to up to $75,000,000 of Common Stock.

 

B.Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, the Company shall cause to be issued to the Investor the Commitment Shares in accordance with the terms of the Purchase Agreement.

…

EX-10.2·8-K·CIK 811222·ACC 0001683168-26-004756·Filed Jun 11, 2026, 16:10 ET

COMMON STOCK PURCHASE AGREEMENT

 

This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of June 5, 2026 (this “Agreement”), by and among Leonite Fund I, LP (the “Investor”), and Cardiff Lexington Corporation, a Nevada corporation (the “Company”).

 

RECiTALS

 

WHEREAS, the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $25,000,000 of the Company’s shares of common stock, $0.001 par value per share (the “Common Stock,” which can be increased, at the Company’s option, to up to $75,000,000 of Common Stock;

…

EX-10.1·8-K·CIK 811222·ACC 0001683168-26-004756·Filed Jun 11, 2026, 16:10 ET

EXHIBIT 10.1

Vireo Growth Inc.

Exhibit 10.1 

CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

 

SECURITIES PURCHASE AGREEMENT

 

by and among

 

VIREO GROWTH INC.,

 

BWAB Holdings LLC,

 

Bridgewell Agribusiness LLC,

 

Agribusiness Holdings Limited Partnership,

 

the Ultimate Sellers set forth on Schedule I hereof,

 

and

 

SHAREHOLDER REPRESENTATIVE SERVICES LLC

 

Dated as of June 5, 2026

 

 

 

 

Table of Contents

 

Page

 

Article I. DEFINITIONS

1

 

 

Article II. PURCHASE AND SALE

20

Section 2.01

Closing

20

Section 2.02

Closing Deliverables

20

Section 2.03

Withholding Rights

22

Section 2.04

Closing Purchase Price and Closing Share Payment Adjustment

23

Section 2.05

Buyer Shares

26

 

 

 

Article III. REPRESENTATIONS AND WARRANTIES of ULTIMATE SELLERS

29

Section 3.01

Organization and Qualification

29

Section 3.02

Authority

30

Section 3.03

…

EX-10.1·8-K·CIK 1771706·ACC 0001104659-26-072936·Filed Jun 11, 2026, 16:06 ET

EX-10.1

GLADSTONE INVESTMENT CORPORATION\DE

AMENDMENT NO. 13

TO

FIFTH AMENDED AND RESTATED CREDIT AGREEMENT

THIS AMENDMENT NO. 13 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of June 10, 2026, is entered into among GLADSTONE BUSINESS INVESTMENT, LLC, as Borrower (the “Borrower”), GLADSTONE MANAGEMENT CORPORATION, as Servicer (the “Servicer”), the Managing Agents party hereto, the Joint Lead Arrangers party hereto, the Lenders party hereto, and KEYBANK NATIONAL ASSOCIATION (“KeyBank”), as Administrative Agent (in such capacity, the “Administrative Agent”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the “Credit Agreement” referred to below.

PRELIMINARY STATEMENTS

A. Reference is made to that certain Fifth Amended and Restated Credit Agreement dated as of April 30, 2013 by and among the Borrower, the Servicer, the Lenders and Managing Agents parties thereto from time to time and the Administrative Agent, (as amended, modified or restated from time to time, the “Credit Agreement”).

…

EX-10.1·8-K·CIK 1321741·ACC 0001193125-26-267511·Filed Jun 11, 2026, 16:05 ET